Increasing medication prescribing in primary care offices and settings could help increase access, Gregory said, but there is still a lot of work to be done in figuring out how to reduce these barriers to care and how to best deliver treatment in the most cost-effective, safe and effective ways
When respiratory symptoms do occur in patients taking GLP-1 medications, they are more commonly attributable to complications of treatment rather than the medication itself
each row is a what-if based on public trial status and typical FDA clocks
100 Identifying triggers: Recognizing situations, emotions (stress, boredom, sadness), or environments that increase food noise
Food and Drug Administration (FDA-c)
For an actual head-to-head, the TRIUMPH-5 trial is currently comparing retatrutide directly against tirzepatide, with primary completion expected in late 2026